“I was inspired to write this book by various people who were waiting to see God move in their lives, those who had to learn how to trust God’s process,” said Little.
Dr. Tiffany A. Little is a highly sought after empowerment specialist, thought leader and advocate for educational and spiritual growth and development. She has a doctorate in Educational Leadership and Superintendence. She is the founder of the nonprofit organization, Composing Minds, Inc. Realizing she had a dual call to both education and ministry; Dr. Little became a Certified Lay Minister of the United Methodist Church. She is the author of My Praise is Greater than My Struggle.
Xulon Press, a division of Salem Media Group, is the world’s largest Christian self-publisher, with more than 20,000 titles published to date. The Appointed Time is available online through xulonpress.com/bookstore, amazon.com, and barnesandnoble.com.
Media Contact
Dr. Tiffany A. Little, Salem Author Services, 704-298-1862, [email protected], tiffanyalittle.org
Additionally, EEG-based signatures represent promising preclinical screens to quickly determine CNS penetration, drug-target engagement, evidence of efficacy, pharmacokinetic/pharmacodynamic profile, CNS safety and toxicity and pro-convulsant risk.
In this webinar, the featured speaker will review the EEG analysis, related optimization parameters and candidate compound selection as well as case studies where EEG-based signatures in correlation with animal behavior could validate the EEG as the endpoint for a set of translatable biomarkers bridging preclinical and clinical programs.
Join this webinar to gain insights into EEG analysis as physiological endpoints to facilitate drug discovery for CNS diseases.
Join Ruiben Feng, PhD, Executive Director, Neurobiology and Neuropharmacology at Shanghai ChemPartner, for the live webinar on Monday, October 16, 2023, at 11am EDT (4pm BST/UK).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
“Phil joins us with strategic, financial, and operational management expertise in both for-profit and not-for-profit healthcare settings and balances his business acumen and clinical expertise with staff engagement, creating a healthy organizational culture and ensuring safe, high-quality care,” said Leah A. Carpenter, FACHE, chief operating officer at Memorial Healthcare System. “He has an impressive track record of hands-on leadership, collaborating directly with leaders, physicians, and staff to meet the needs of patients, families, and communities in an ever-changing healthcare environment.”
A native of Gainesville, Florida, Wright takes over for the recently-retired Douglas Zaren. At Memorial Regional Hospital South, he will oversee a 280-bed facility that offers a wide range of healthcare services in a compassionate, collaborative setting. It is home to the Memorial Rehabilitation Institute, South Florida’s largest provider of physical rehabilitation services, and includes a rehab unit specifically tailored to the needs of medically-complex patients. The hospital also offers emergency care, women’s services, a sports medicine center, and adaptive sports program.
South Florida-based Memorial Healthcare System (http://www.mhs.net) is a national leader in quality care and patient, physician, and employee satisfaction. Its commitment to deeper caring and smarter health prioritizes a person-centered approach that has delivered safe, positive outcomes for 70 years.
Featuring multi-disciplinary collaboration, research, innovation, and transparency within its many facilities, Memorial is focused on removing barriers, increasing access, and providing equitable care throughout the region. It employs a staff of more than 16,000 and operates six hospitals, numerous primary, urgent, and 24/7 care facilities, medical office buildings, a health specialty center, and nursing home.
To learn more, visit mhs.net and connect on Facebook, Twitter, Instagram, YouTube, and LinkedIn.
Join this webinar and learn from their experiences about what makes an excellent rater for these scales, how to take a targeted and tailored rater training approach based on common administration errors, and ways to catch rater drift before it becomes problematic. The presenters will also describe an approach called central rating that can increase quality and consistency while reducing site burden and heightening diversity.
Join experts from Cogstate, Kim Baldwin, Associate Director, Clinician Network; Felice Ockun, Senior Manager, Clinician Network, Clinical Trials; and Janelle Eloi, PhD, Principal Clinical Scientist, Licensed Neuropsychologist, for the live webinar on Wednesday, October 18, 2023, at 11am EDT (4pm BST/UK).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Join this informative webinar to gain insights into the best use of PCR methods in the pre-clinical and clinical development of vaccines and other biotherapeutics.
Join Manisha R. Diaz, PhD, Associate Director of Research and Development, Eurofins Viracor BioPharma Services; Deepak Tomar, PhD, Senior Scientific Lab Lead, Eurofins Bioanalytical Services; and Erik Jerks, PhD, Director of Bioanalytical Services, Eurofins Bioanalytical Services, for the live webinar on Friday, October 13, 2023, at 11am EDT (4pm BST/UK).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
This webinar will focus on best practices to navigate regulatory communications with the US FDA and how this guidance may inform pharma and biotech companies on the development of manufacturing, non-clinical development plans and investigational approaches.
Join this webinar to get insights on the US FDA guidelines and the managing of safety considerations and efficacy endpoints of these cell and gene therapy products.
Join experts from Emmes, Robert Anderson, PhD, Associate VP, Regulatory; and Kari Bingham, PharmD, CGT Safety Manager, Pharmacovigilance and Medical Monitoring, for the live webinar on Monday, October 16, 2023, at 11am EDT (4pm BST/UK).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Carestream NDT also is sponsoring ASNT’s keynote speaking event featuring John Register, a Paralympic silver medalist, Gulf War veteran, and U.S. Department of State Sports Envoy, who will share his perspective on overcoming adversity.
“John’s story is about not only meeting significant challenges head-on, but also overcoming them with impressive outcomes. We truly look forward to hearing that story and reflecting on the related implications,” said Mr. Dickson.
In addition to sponsoring the keynote, Carestream NDT will showcase its innovative, award-winning line of computed radiography (CR) systems and digital radiography (DR) detectors that have expanded to meet the needs of the NDT industry. Specifically, the groundbreaking HPX-DR family of detectors for demanding NDT applications offer:
Non-glass panels for improved durability
High resolution for critical defect detection
High speed for faster throughput in busy operations
Compact units to test in narrow environments
Large-format units to image a broad range of objects
The company’s HPX-CRs —HPX-1 Plus Digital System and HPX-PRO Portable Digital System—will also be on display at ASNT to demonstrate how Carestream NDT’s advanced solutions make industrial radiography easier, more productive, and more accurate. Furthermore, Carestream NDT will showcase its ongoing investment in the all-in-one INDUSTREX Digital Viewing Software platform along with INDUSTREX Film and Processors that produce clear, inspection-quality images in minutes.
For those who want to sharpen their skills in industrial radiography, Carestream NDT representatives will be on hand discussing our joint effort with the American Institute of Nondestructive Testing to offer specialized training programs through the Advanced Industrial Radiographic Training Academy.
About Carestream Health Carestream is a worldwide provider of medical imaging systems; X-ray imaging systems for non-destructive testing; and precision contract coating services for a wide range of industrial, medical, electronic, and other applications—all backed by a global service and support network. For more information about the company’s broad portfolio of products, solutions, and services, please contact your Carestream representative, or call 1-888-777-2072, or visit http://www.carestream.com.
In this free webinar, gain insights into how to use model-informed drug development in oncology to support dose selection in agreement with the FDA’s Project Optimus Goals. The FDA’s increased recommendations for oncology dose justification beyond maximum tolerated dose (MTD) have increased interest in quantitative methods and their application to oncology.
TORONTO , Oct. 4, 2023 /PRNewswire-PRWeb/ — Discover a groundbreaking webinar delving into the application of model informed drug development (MIDD) in oncology to support dose selection. The Food and Drug Administration’s (FDA) increased recommendations for oncology dose justification beyond maximum tolerated dose (MTD) have increased interest in quantitative methods and their application to oncology.
This webinar will review the updated recommendations and overview the platform of tools used for MIDD so that attendees can design their experimental path to ensure they gather appropriate and sufficient data to inform pharmacometrics modeling and increase the scientific justification of their dose selection for first-in human (FIH) to pivotal studies.
Join this webinar to gain insights into how to use model informed drug development in oncology to support dose selection in agreement with the FDA’s Project Optimus Goals.
Join Angelean Hendrix, Senior Director, Quantitative Clinical Pharmacology, Amador BioScience, for the live webinar on Wednesday, October 11, 2023, at 12pm EDT (9am PDT).
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Dedicated to training the next generation of world-class physicians, UMHS provides personalized medical education with an 8:1 student-to-faculty ratio and unparalleled support. UMHS students also have access to UMHS’s state-of-the-art facilities and clinical rotations at leading teaching hospitals throughout the United States for superior training that positions graduates for prestigious residency placements. This year, UMHS celebrated one of the most successful Match Days in the school’s history – with students securing residencies in 11 medical specialties across 24 states and territories, including multiple matches in California, Texas, Michigan, and Puerto Rico, and the school’s first matches in Oregon and New Hampshire. UMHS also reached new milestones for Canadian students, who placed directly into residencies through CaRMS, including its first-ever match in Alberta.
“We’re pleased to partner with Larkin University, a school that shares our vision of educating uniquely skilled and diverse medical professionals eager to meet the need for physicians in various settings, and reflecting the demographics of the communities we serve,” said Warren Ross, president of UMHS. “LU is focused on educational programs, research and scholarly activity, and development of solutions that promote the common good of health care and society, and we look forward to building on that foundation as we provide the training for highly skilled, resilient, and empathetic doctors. We’re excited to welcome qualified LU graduates to the UMHS family.”
UMHS has articulation agreements with several undergraduate institutions in the U.S. and Canada. These agreements enable a prospective student from a partnering university to automatically qualify for admission to UMHS after meeting the minimum standards defined by the articulation agreement. For a complete list of schools that have partnered with UMHS and an overview of admission requirements, please visit https://www.umhs-sk.org/articulation-agreements.
About UMHS The University of Medicine and Health Sciences (UMHS), is a small, mission-driven medical school with a commitment to student support and a legacy of successful residency placements in the United States and Canada. UMHS was founded in 2007 by medical education pioneers Warren and Robert Ross to deliver a highly personalized school experience. Graduates of UMHS earn a Doctor of Medicine degree (MD) and qualify to practice medicine throughout the United States and Canada. Students begin their Basic Science studies in St. Kitts, West Indies, and complete their clinical training in the United States. With an unprecedented 96% student retention rate, the vast majority of students that begin their medical studies at UMHS go on to obtain residencies. For more information, visit https://www.umhs-sk.org/.
Optmyzr Sidekick is the latest addition to Optmyzr’s extensive suite of machine learning AI technologies that have long been trusted by advertisers worldwide. This cutting-edge capability harnesses the power of advanced natural language processing and machine learning algorithms to deliver a range of key features and benefits:
Performance Summaries: Optmyzr Sidekick offers advertisers an instant snapshot of their PPC ad account performance, presenting essential metrics and trends in a user-friendly format. Users can easily track and monitor performance changes, identifying strengths and areas for improvement.
Performance Explanations: Understanding why performance changes occur is crucial for advertisers seeking to make data-driven decisions. Optmyzr Sidekick leverages its generative AI capabilities to provide clear and concise explanations for performance fluctuations, helping advertisers pinpoint the underlying factors driving the changes.
Optimization Suggestions: Armed with intelligent insights, Optmyzr Sidekick generates actionable optimization suggestions tailored to each advertiser’s unique goals and objectives. From bid adjustments to ad copy improvements, these recommendations empower advertisers to take proactive steps to enhance their campaign performance.
Account Highlights: In addition to identifying areas for improvement, Optmyzr Sidekick also highlights the positive aspects of an advertiser’s PPC ad account. By showcasing success stories, campaign milestones, and top-performing segments, the capability offers advertisers a well-rounded perspective on their achievements.
“Optmyzr Sidekick marks a significant milestone in our ongoing commitment to empowering advertisers with innovative automation solutions,” said Fred Vallaeys, CEO at Optmyzr. “Our generative AI capability combines cutting-edge technology with deep industry expertise to deliver comprehensive insights and actionable recommendations that can transform the way advertisers manage and optimize their PPC campaigns.”
Optmyzr Sidekick is seamlessly integrated into the Optmyzr platform, allowing advertisers to harness its power within their existing workflows. By combining the capabilities of Optmyzr’s existing machine learning AI solutions with Optmyzr Sidekick, advertisers gain an unparalleled advantage in maximizing the potential of their PPC ad accounts.
For more information about Optmyzr Sidekick and Optmyzr Inc’s suite of digital marketing automation solutions, visit https://www.optmyzr.com.
